SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Link Pharma Chem - Quaterly Results

09 Feb 2023 Evaluate
The sales moved down -33.25% to Rs. 93.64 millions for the December 2022 quarter as compared to Rs. 140.28 millions during the corresponding quarter last year.Profit after Tax for the quarter ended December 2022 saw a decline of -74.54% from Rs. 7.03 millions to Rs. 1.79  millions.A decline of 7.29 millions was observed in the OP in the quarter ended December 2022 from 13.63 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 93.64 140.28 -33.25 294.67 422.72 -30.29 535.61 348.13 53.85
Other Income 0.81 3.21 -74.77 -1.22 3.57 -134.17 4.64 0.21 2109.52
PBIDT 7.29 13.63 -46.52 23.15 33.58 -31.06 40.01 29.92 33.72
Interest 1.92 1.56 23.08 5.01 4.07 23.10 4.51 4.40 2.50
PBDT 5.37 12.07 -55.51 18.14 29.51 -38.53 35.50 25.52 39.11
Depreciation 2.38 2.18 9.17 6.92 6.54 5.81 9.28 8.74 6.18
PBT 2.99 9.89 -69.77 11.22 22.97 -51.15 26.22 16.78 56.26
TAX 1.20 2.86 -58.04 2.73 6.88 -60.32 7.40 5.94 24.58
Deferred Tax 0.64 0.00 0.00 -1.35 1.07 -226.17 -0.01 -0.47 -97.87
PAT 1.79 7.03 -74.54 8.49 16.09 -47.23 18.82 10.84 73.62
Equity 44.41 44.41 0.00 44.41 44.41 0.00 44.41 44.41 0.00
PBIDTM(%) 7.79 9.72 -19.88 7.86 7.94 -1.10 7.47 8.59 -13.08

Link Pharma Chem Share Price

29.49 1.49 (5.32%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×